Orgenesis (ORGS) Stock Chart & Stock Price History $0.02 0.00 (0.00%) As of 08/14/2025 03:32 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Orgenesis Stock Price Performance The Orgenesis (ORGS) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 98.84%. In the past month, the stock has decreased 98.15%, reflecting recent market activity. As of the latest close, Orgenesis traded at $0.02 with a market cap of $106 thousand and volume of 1,122 shares. Receive ORGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-97.53%1 Month Performance-98.15%3 Month Performance-98.98%Year-To-Date Performance-98.84% ORGS Stock Chart for Friday, August, 15, 2025 ORGS Chart by TradingView Orgenesis Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$0.02$0.02$1.00$0.021,122 shs$106,000.0008/13/2025$0.02$0.02$0.89$0.025,444 shs$106,000.0008/12/2025$0.80$0.02-97.25%$0.79$0.021,999 shs$106,000.0008/11/2025$0.89$0.80-10.11%$0.89$0.80350 shs$3.84 million08/08/2025$0.06$0.89+1,359.02%$0.89$0.89150 shs$4.27 million08/07/2025$0.02$0.06+177.27%$0.80$0.06404 shs$293,000.0008/06/2025$0.02$0.02$0.88$0.021,200 shs$106,000.0008/05/2025$0.11$0.02-80.18%$0.11$0.022,290 shs$106,000.0008/04/2025$1.00$0.11-88.90%$0.11$0.11165 shs$533,000.0008/01/2025$0.02$1.00+4,445.45%$1.00$0.021,114 shs$4.80 million Get the Latest News and Ratings for ORGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$0.90$0.02-97.56%$0.89$0.021,396 shs$106,000.0007/30/2025$0.00$0.90+899,900.00%$0.90$0.90188 shs$4.32 million07/29/2025$1.00$0.00-99.99%$0.00$0.003,150 shs$0.0007/28/2025$1.00$1.00$1.00$1.00135 shs$4.80 million07/25/2025$1.00$1.00$1.00$0.003,300 shs$4.80 million07/24/2025$1.00$1.00$1.00$0.25200 shs$4.80 million07/23/2025$1.01$1.00-0.99%$1.00$0.25200 shs$4.80 million07/22/2025$1.01$1.01$1.08$0.0011,698 shs$4.85 million07/21/2025$1.04$1.01-2.88%$1.08$0.0011,698 shs$4.85 million07/18/2025$1.11$1.04-6.31%$1.04$1.04456 shs$4.99 million07/17/2025$1.12$1.11-0.89%$1.12$1.112,420 shs$5.33 million07/16/2025$1.19$1.12-5.88%$1.17$1.1011,980 shs$5.38 million07/15/2025$1.18$1.19+0.85%$1.21$1.134,844 shs$5.71 million07/14/2025$1.07$1.18+10.28%$1.30$1.007,381 shs$5.66 million Related Companies Gelteq Stock Price Chart Abpro Stock Price Chart Athira Pharma Stock Price Chart Allarity Therapeutics Stock Price Chart Cyclacel Pharmaceuticals Stock Price Chart Marker Therapeutics Stock Price Chart Ainos Stock Price Chart Neuphoria Therapeutics Stock Price Chart Citius Pharmaceuticals Stock Price Chart AlloVir Stock Price Chart Receive ORGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORGS) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orgenesis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orgenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access